EGFR-IN-210 is a EGFR kinase inhibitor with an IC50 of 0.198 µM. EGFR-IN-210 induces antiproliferative, pro-apoptotic, G0/G1 cell cycle arrest, DNA synthesis inhibition and anti-migratory effects in cancer cells. EGFR-IN-210 can be used for the research of various cancers including colorectal cancer[1].
Molecular Weight:
630.14
Formula:
C30H24ClN7O3S2
Target:
Apoptosis,DNA/RNA Synthesis,EGFR
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
